NOWDiagnostics, Inc. (NOWDx) is a prominent developer and manufacturer of over-the-counter (OTC) and point-of-care (POC) diagnostic tests. Founded in 2014, the company is headquartered in Springdale, Arkansas, USA. Its innovative diagnostic solutions utilize a simple drop of blood or saliva to deliver rapid test results onsite, empowering both patients and healthcare providers. As of 2024, the company has raised significant funding, including a recent $22.5 million Series B round led by DigitalDx Ventures, enhancing its capabilities in rapid healthcare diagnostics. NOWDiagnostics was founded by an innovative group and has Kristian Andersen as a significant team member.
| Attribute | Information |
|---|---|
| Founding Date | 2014 |
| Headquarters | Springdale, Arkansas, USA |
| Founders | Key Founders not publicly disclosed |
| Revenue | $26 million (2024) |
| Profits | Not publicly disclosed |
| Key Investors | DigitalDx Ventures, Labcorp Venture Fund, Kompass Kapital Management |
| Industry | Healthcare Diagnostics |
| Number of Employees | Information not specifically disclosed |
NOWDiagnostics was founded in 2014 with a vision to revolutionize the diagnostics industry by providing fast, accurate, and accessible testing solutions. Early in its journey, the company focused on developing its ADEXUSDx® product line, which incorporates a laboratory-like capability at consumers' fingertips. Initially targeting the hCG (pregnancy), cardiac, and toxicology markets, NOWDx capitalized on its unique technology, allowing tests to be conducted with just a drop of blood or saliva. This revolutionary approach won them several patents and rapid acclaim within the medical diagnostics community, setting the foundation for expanding their product line and entering new markets.
NOWDiagnostics operates with a business model focused on high-impact diagnostics across both over-the-counter and clinical service markets. Their innovative ADEXUSDx® platform allows various immunological assays to be executed onsite with minimal biological samples. Major achievements include:
NOWDiagnostics presently emphasizes the development of innovative diagnostic tests that cater to a wide array of health fields, including cardiac, infectious diseases, and prenatal health. The firm's unique selling proposition centers on the rapidity and convenience of 'Touch to Test' diagnostics, which provide lab-accurate results in person, eliminating the delays traditionally associated with sending tests to offsite facilities. With a robust product development pipeline and a strategic focus on at-home and point-of-care testing, NOWDx is ideally positioned to capitalize on the growing demand for rapid dynamics in the diagnostics market, a sector that is expected to see significant growth in upcoming years.
NOWDiagnostics stands at a pivotal juncture in the healthcare diagnostics landscape, having established itself as a leader in rapid, at-home testing solutions. With a commitment to making healthcare decisions more informed and accessible, the company's ongoing innovation and strategic efforts are key to their potential success. Looking ahead, NOWDx aims to expand its reach and impact by continuing to enhance its technology and product offerings, thus improving healthcare outcomes across the globe. As the demand for home-based diagnostics continues to rise, NOWDx’s approach could play a crucial role in shaping the future of medical diagnostics.